Rights and permissions
About this article
Cite this article
QOL similar for gemcitabine with cisplatin or epirubicin in NSCLC. Pharmacoecon. Outcomes News 445, 14 (2004). https://doi.org/10.2165/00151234-200404450-00033
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404450-00033